Health Care

Biotech & Healthcare Webinar Recap – Antisense Therapeutics (ASX:ANP)



Prev1 of 2
Use your ← → (arrow) keys to browse

In this one of a four-part webinar recap, Mark Diamond, Managing Director & CEO of Antisense Therapeutics Limited (ASX:ANP) presented on the company’s latest announcements and updates, while answering some questions during the Q&A session at the end.

StockPal hosted its first Biotech & Healthcare webinar on 4 August for four ASX- and NASDAQ-listed health care companies. This webinar is co-organised with Rawson Lewis.

Download the full presentation here:

Subscribe to our mailing list to stay up-to-date with future events and company updates.

The companies that participated were as follows:
Recce Pharmaceuticals (ASX:RCE) – James Graham (Executive Director) –

Antisense Therapeutics (ASX:ANP) – Mark Diamond (Managing Director) –

Medlab (ASX:MDC) – Sean Hall (Chief Executive Officer, MD) –

Aptorum Group (NASDAQ:APM) – Darren Lui (President and Executive Director) –


Prev1 of 2
Use your ← → (arrow) keys to browse

Click to comment